The product, honestly shown
One workflow,
shown end to end.
Five accountable steps between visits — shown here with synthetic data, labeled with their limits, and walked live in a design-partner conversation.
Step 1 · Participate
The patient shares on their terms.
Depending on the organization’s approved workflow, patients can check in, complete assigned assessments, prepare for their next session, keep safety-plan access at hand, and ask their care team questions. Sharing is scoped, understandable, and always the patient’s choice.
Illustrative product view · synthetic names and data
Step 2 · Prepare
Approved inputs become encounter context.
What the patient chose to share is composed into a source-visible preparation view for the next encounter. Nothing is invented: every item traces to an approved record, and gaps are shown as gaps.
Session with Jordan K.
Three inputs shared since the last visit. Every item below traces to a source Jordan chose to share.
Anxiety drifting up. Depression stable.
Step 3 · Review
Licensed judgment stays in charge.
Clinicians review inputs and, where an organization has approved and enabled it, source-grounded drafts with visible citations. A draft never applies itself and never becomes a clinical decision without a licensed reviewer.
Your caseload, today.
Two patients need attention before 5 pm. The rest are steady.
Step 4 · Respond
Follow-through has a named owner.
Responses, handoffs, and escalations follow the organization’s own policy. An acknowledged item requires a recorded disposition — signals do not disappear into an unowned stream.
Illustrative product view · synthetic names and data
Step 5 · Evidence
The organization can inspect the loop.
Participation, review, action, and exceptions are inspectable at the organizational level without exposing an individual patient’s record: cohort views are de-identified and small groups are suppressed by design.
Who did what, and when — with receipts.
Consequential actions land in an append-only record: reviews, disclosures, dispositions, and governance decisions.
What we do not show
Restraint is part of the product.
These previews use synthetic names and data, and that is not a disclaimer of convenience: we do not display live-patient records, publish usage metrics without an approved source, show crisis-prediction features, or demonstrate autonomous replies — because those are not honest representations of the product’s current, governed state.
See it live
The real walkthrough happens in conversation.
Design-partner conversations include a live, synthetic-data walkthrough of each step against your organization’s own workflow — with the boundaries and open questions stated as plainly as the capabilities.
Walk the workflow
See each step against your own process.
Email the organization name, your role, and the between-session process you want to improve. Do not include PHI.
Request a walkthrough Do not include patient information or clinical details in email.